Cargando…
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards “Personalized Medicine” in Daily Clinical Practice
Diagnostic and treatment strategies for acute coronary syndrome have improved dramatically over the past few decades, but mortality and recurrent myocardial infarction rates remain high. An aging population with increasing co-morbidities heralds new clinical challenges. Therefore, in order to evalua...
Autores principales: | Chan Pin Yin, Dean R. P. P., Vos, Gert-Jan A., van der Sangen, Niels M. R., Walhout, Ronald, Tjon Joe Gin, R. Melvyn, Nicastia, Deborah M., Langerveld, Jorina, Claassens, Daniël M. F., Gimbel, Marieke E., Azzahhafi, Jaouad, Bor, Willem L., Oirbans, Tom, Dekker, Johan, Vlachojannis, Georgios J., van Bommel, Rutger J., Appelman, Yolande, Henriques, José P. S., Kikkert, Wouter J., ten Berg, Jurriën M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601438/ https://www.ncbi.nlm.nih.gov/pubmed/33007932 http://dx.doi.org/10.3390/jcm9103173 |
Ejemplares similares
-
External validation of the GRACE risk score and the risk–treatment paradox in patients with acute coronary syndrome
por: van der Sangen, Niels M R, et al.
Publicado: (2022) -
Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
por: van der Sangen, Niels M R, et al.
Publicado: (2023) -
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study
por: Azzahhafi, Jaouad, et al.
Publicado: (2022) -
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials
por: van den Broek, Wout W. A., et al.
Publicado: (2023) -
One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome
por: van der Sangen, Niels M R, et al.
Publicado: (2023)